A third of young men who have sex with men (MSM) discontinue pre-exposure prophylaxis (PrEP) within a six-month period, investigators from the United States report in AIDS and Behavior. Common reasons for stopping included being unable to get an appointment with a doctor and problems ...

Taking large numbers of medications in addition to antiretroviral therapy (ART) is associated with an increased risk of hospitalisation and death for HIV-positive individuals, investigators from the US Department of Veterans Affairs report in AIDS.

Prevalence of silent cerebral small-vessel disease (SCSVD) – an important precursor to more serious neurocognitive conditions – is significantly higher among middle-aged HIV-positive patients compared to controls in the general population, according to French research published in Clinical Infectious Diseases.

People with HIV taking antiretroviral treatment who had undetectable viral load did not suffer any loss of cognitive function or brain volume during a two-year period when compared with their HIV-negative peers, but did have lower cognitive function and brain volume at the start of ...

Reducing the size of the HIV reservoir is viewed as an essential step in achieving a cure for HIV infection

HVTN 705 vaccine study passes its “go” criteria: due to start this autumn A year ago, one of the biggest pieces of prevention news at the Durban International AIDS Conference was the announcement that a large HIV vaccine efficacy study would start in South Africa. HVTN 702, ...

The number of new HIV diagnoses in gay men attending five key London clinics fell substantially during 2015 and 2016, Valerie Delpech of Public Health England told the British HIV Association (BHIVA) conference in Liverpool yesterday. Epidemiological analysis shows that the phenomenon is real. Diagnoses fell ...

An international group of researchers involved in the ANRS 12174 randomised controlled trial of pre-exposure prophylaxis (PrEP) for infants say that it is high time we started giving PrEP to all breastfed babies of HIV-positive mothers in countries where the likelihood of transmission via breastfeeding ...

After three years, tenofovir alafenamide (TAF) for first-line HIV treatment was better at suppressing viral load and safer for the bones and kidneys than the older tenofovir disoproxil fumarate (TDF), researchers reported at the 2017 Conference on Retroviruses and Opportunistic Infections (CROI 2017) last month in ...

Bictegravir, an investigational integrase inhibitor from Gilead Sciences, was highly potent, well tolerated and worked as well as dolutegravir (Tivcay) in a phase 2 clinical trial, according to study results presented on Tuesday at the 2017 Conference on Retroviruses and Opportunistic Infections (CROI) in Seattle ...

This week Large drop in HIV diagnoses in London gay men Four sexual health clinics serving large numbers of gay men in London have reported that they diagnosed far fewer gay men with HIV during Hepatitis C virus often found in rectal fluid Our understanding of how ...

This week HIV transmission and antiretroviral therapy Antiretroviral treatment greatly reduces the risk of transmitting HIV. Several very large studies have now shown that people with undetectable viral load do not Sex after HIV diagnosis To what extent do gay men modify their sexual risk behaviour after ...

This week Cheap, imported generic hepatitis C drugs work well A major conference on hepatitis treatment heard lots more good news about the new drugs for hepatitis C. For example, a single pill combining Dropping out of care UK researchers are trying to understand more about the ...